Literature DB >> 7371001

Effects of estrogen and antiestrogen on DNA polymerase in human breast cancer.

D P Edwards, S R Murthy, W L McGuire.   

Abstract

We have investigated the effects of estrogens and antiestrogens on cellular DNA-dependent DNA polymerase activity in human breast cancer, using as a model the MCF-7 human breast cancer cell line which contains estrogen receptor. 17 beta-Estradiol had little if any effect on cytosol DNA polymerase activity or growth (total DNA per flask) of MCF-7 cells. Incubation of the cells for 4 to 6 days with the antiestrogen nafoxidine, however, resulted in a dose-dependent reduction in cytosol DNA polymerase activity to one-half that observed in untreated cells. Enzyme activity in antiestrogen-treated cells was restored to levels contained in untreated cells by removing antiestrogen from the growth medium and incubating the cells for an additional 4 days with 17 beta-estradiol. The restoration required estrogenic steroids specifically, and the time course, magnitude, and dose dependence of the response were similar to estrogen-stimulated increases in DNA polymerase activity described in other estrogen target tissues. Estrogen-mediated reversal of antiestrogen suppression of DNA polymerase activity was paralleled by increases in total DNA synthesis.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7371001

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  10 in total

1.  Identification of estrogen-inducible growth factors (estromedins) for rat and human mammary tumor cells in culture.

Authors:  T Ikeda; Q F Liu; D Danielpour; J B Officer; M Iio; F E Leland; D A Sirbasku
Journal:  In Vitro       Date:  1982-12

2.  8th San Antonio Breast Cancer Symposium--Plenary lecture. Autocrine and paracrine growth regulation of human breast cancer.

Authors:  M E Lippman; R B Dickson; S Bates; C Knabbe; K Huff; S Swain; M McManaway; D Bronzert; A Kasid; E P Gelmann
Journal:  Breast Cancer Res Treat       Date:  1986       Impact factor: 4.872

3.  Biological differences among MCF-7 human breast cancer cell lines from different laboratories.

Authors:  C K Osborne; K Hobbs; J M Trent
Journal:  Breast Cancer Res Treat       Date:  1987       Impact factor: 4.872

4.  Cell cycle synchronization induced by tamoxifen and 17 beta-estradiol on MCF-7 cells using flow cytometry and a monoclonal antibody against bromodeoxyuridine.

Authors:  S Bruno; A Di Vinci; E Geido; W Giaretti
Journal:  Breast Cancer Res Treat       Date:  1988-07       Impact factor: 4.872

Review 5.  Metabolites of tamoxifen in animals and man: identification, pharmacology, and significance.

Authors:  V C Jordan
Journal:  Breast Cancer Res Treat       Date:  1982       Impact factor: 4.872

6.  A cDNA for the estradiol-regulated 24K protein: control of mRNA levels in MCF-7 cells.

Authors:  I Moretti-Rojas; S A Fuqua; R A Montgomery; W L McGuire
Journal:  Breast Cancer Res Treat       Date:  1988-05       Impact factor: 4.872

Review 7.  Antiestrogen resistance in ER positive breast cancer cells.

Authors:  S Paik; D P Hartmann; R B Dickson; M E Lippman
Journal:  Breast Cancer Res Treat       Date:  1994       Impact factor: 4.872

8.  Analysis by DNA polymerase alpha activity of human breast tumour proliferation and the effect of endocrine therapy.

Authors:  N G Coldham; L C Lai; M J Reed; M W Ghilchik; N A Shaikh; V H James
Journal:  Br J Cancer       Date:  1990-08       Impact factor: 7.640

Review 9.  Mitogenic regulation of normal and malignant breast epithelium.

Authors:  M E Lippman; R B Dickson
Journal:  Yale J Biol Med       Date:  1989 Sep-Oct

10.  Interrelationship between estradiol and tamoxifen responses for clinical breast carcinoma cells cultured on contact-sensitive plates.

Authors:  H Matsuoka; Y Nakamura; H Ueo; K Sugimachi; H Tomoda; T Saito; Y Seo
Journal:  Jpn J Cancer Res       Date:  1994-06
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.